These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3090394)

  • 21. Dopamine receptor changes in response to prolonged treatment with L-dopa.
    Groppetti A; Flauto C; Parati E; Vescovi A; Rusconi L; Parenti M
    J Neural Transm Suppl; 1986; 22():33-45. PubMed ID: 2946813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of the increase in apomorphine-induced stereotypy and aggression in REM sleep deprived rats by dopamine agonist pretreatments.
    Troncone LR; Ferreira TM; Braz S; Silveira Filho NG; Tufik S
    Psychopharmacology (Berl); 1988; 94(1):79-83. PubMed ID: 3126531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
    Johnson AM; Loew DM; Vigouret JM
    Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The comparative long-term effects of ciladopa (AY-27,110), a chemically novel dopaminergic agonist, in 6-OHDA-lesioned and intact rats.
    Voith K
    Psychopharmacology (Berl); 1985; 85(4):405-9. PubMed ID: 3927334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects on phrenic output of two dopamine agonists, apomorphine and bromocriptine.
    Nielsen AM; Bisgard GE
    Eur J Pharmacol; 1984 Oct; 106(1):69-78. PubMed ID: 6529974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of bromocriptine in developing rat pups after 6-hydroxydopamine.
    Shaywitz BA; Lipton SV; Teicher MH; Cohen DJ; Anderson GM; Batter DK; Young JG
    Pharmacol Biochem Behav; 1981 Sep; 15(3):443-8. PubMed ID: 6794039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Troponoids. 6. Troponylpiperazines: a new class of dopamine agonists.
    Bagli J; Bogri T; Voith K
    J Med Chem; 1984 Jul; 27(7):875-81. PubMed ID: 6429333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of age on behavioral responses to dopamine agonists in the rat.
    Ushijima I; Mizuki Y; Soeda K; Kishimoto O; Hara T; Yamada M
    Eur J Pharmacol; 1987 Jun; 138(1):101-6. PubMed ID: 2887433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the mechanism of the antiparkinsonian action of 1-DOPA and bromocriptine: a theoretical and experimental analysis of dopamine receptor sub- and supersensitivity.
    Agnati LF; Fuxe K
    J Neural Transm Suppl; 1980; (16):69-81. PubMed ID: 7000979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reinstatement of eating by dopamine agonists in aphagic dopamine denervated rats.
    Ljungberg T; Ungerstedt U
    Physiol Behav; 1976 Mar; 16(3):277-83. PubMed ID: 1033572
    [No Abstract]   [Full Text] [Related]  

  • 33. Dopamine D1- and D2-receptor interaction in turning behaviour induced by dopamine agonists in 6-hydroxydopamine-lesioned rats.
    Karlsson G; Jaton AL; Vigouret JM
    Neurosci Lett; 1988 May; 88(1):69-74. PubMed ID: 2969468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Terguride, a mixed dopamine agonist-antagonist, in animal models of Parkinson's disease.
    Koller WC; Herbster G
    Neurology; 1987 Apr; 37(4):723-7. PubMed ID: 3561789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repeated stimulation of D-1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion.
    Rouillard C; Bédard P; Falardeau P; Di Paolo T
    Eur J Pharmacol; 1988 Nov; 157(2-3):125-33. PubMed ID: 2975996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of supersensitivity of pre- and postsynaptic dopamine receptors on the activity of endogenous inhibitor of cAMP dependent protein kinase in rat striatum.
    Szmigielski A; Szadowska A; Szmigielska H
    Arch Int Pharmacodyn Ther; 1984 Dec; 272(2):214-24. PubMed ID: 6098230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine agonist activities of pergolide, its metabolites, and bromocriptine as measured by prolactin inhibition, compulsive turning, and stereotypic behavior.
    Clemens JA; Okimura T; Smalstig EB
    Arzneimittelforschung; 1993 Mar; 43(3):281-6. PubMed ID: 8489554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circling behavior in normoxic or hypoxic rats with unilateral 6-OHDA nigrostriatal lesion. Part 1. Effects of apomorphine and L-dopa.
    Saligaut C; Daoust M; Moore N; Boismare F
    Methods Find Exp Clin Pharmacol; 1987 Apr; 9(4):219-24. PubMed ID: 3110513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of chronic dietary lithium on behavioral indices of dopamine denervation supersensitivity in the rat.
    Swerdlow NR; Lee D; Koob GF; Vaccarino FJ
    J Pharmacol Exp Ther; 1985 Nov; 235(2):324-9. PubMed ID: 3932641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conditioning of the early behavioral response to apomorphine in the rotational model of Parkinson's disease.
    Burunat E; Castro R; Díaz-Palarea MD; Rodríguez M
    Eur J Pharmacol; 1988 Jan; 145(3):323-7. PubMed ID: 3127225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.